老年8查工具分数在老年和非老年癌症患者中的分布
Hideki Shimaoka1, Yoichiro Yoshida2,3, Teppei Yamada1
1Department of Gastroenterological Surgery, Fukuoka University Faculty of Medicine, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.
International journal of clinical oncology
|January 8, 2025
概括
老年8 (G8) 查工具显示,功能衰退的癌症患者的得分较低,70岁后显著下降. G8最有效用于查65岁及以上的患者.
科学领域:
- 老年瘤学 老年瘤学
- 癌症查工具 癌症查工具
- 衰老和健康 衰老和健康
背景情况:
- 人口老龄化和癌症发病率上升需要对老年癌症患者提供有效的工具.
- 老年病8 (G8) 工具屏幕用于全面的老年病评估需求.
- 八国集团工具对特定年龄群体的有用性仍未得到充分探索.
研究的目的:
- 评估G8查工具与年龄相关的意义和有用性.
- 在癌症患者中检查不同年龄组 (≥30岁) 的G8分数.
- 为了将G8分数与其他老年医疗评估措施相关联.
主要方法:
- 这项研究包括715名30岁以上的胃肠道癌症患者.
- 进行G8查,收集年龄,G8分数,ADL,IADL和CCI的数据.
- 统计分析调查了年龄,G8,ADL,IADL和CCI之间的关系.
主要成果:
- 随着年龄的增长,G8得分下降,尤其是70岁后.
- 功能障碍患者 (ADL/IADL) 的G8得分明显较低 (p<0.001).
- 随着查尔森并发症指数 (CCI) 的上升,G8的得分下降.
结论:
- G8分数反映了癌症患者的功能衰退和随着年龄的增长而下降.
- 虽然G8对65岁以下的患者敏感,但其效用在65岁以上的患者中最为明显.
- 建议将G8查限制在65岁及以上的患者身上,以获得最佳的效率.
相关概念视频
Drug Dosing: Geriatric Patients
400
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
400
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
868
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
868
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
387
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
387
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
405
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
405
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
358
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
358
Pharmacodynamics in Geriatric Patients: Effects of Age
376
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
376


